longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Medtide Inc.

03880

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 15.02, within the reasonable range, cheaper than 54.41% of the time in the past 1 years, and the industry ranks 2/15, the industry Median 16.79.

15.02xP/E
HK$20.62Stock price
HK$1.37Earnings per share
15.02xP/E
Stock priceHK$20.62Earnings per shareHK$1.37

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
26.05x
Typical range
13.03x–35.07x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 16.79x
014284256

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 16.79x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
06127HKJOINN
16.79x168.39%HK$19.03B
01873HKVIVA BIOTECH
14.96x--HK$3.07B
03880HKMedtide Inc.
15.02x--HK$2.92B
06118HKAUSTAR
18.30x--HK$363.93M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.